Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study
Open Access
- 20 May 2008
- journal article
- Published by Springer Nature in BMC Public Health
- Vol. 8 (1) , 167
- https://doi.org/10.1186/1471-2458-8-167
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Guidance for GuidelinesNew England Journal of Medicine, 2007
- Determinants for the adoption of angiotensin II receptor blockers by general practitionersSocial Science & Medicine, 2006
- Educating Health Professionals about Drug and Device Promotion: Advocates' RecommendationsPLoS Medicine, 2006
- Advertising in Medical Journals: Should Current Practices Change?PLoS Medicine, 2006
- First-Line First? Trends in Thiazide Prescribing for Hypertensive SeniorsPLoS Medicine, 2005
- Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional surveyQuality and Safety in Health Care, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood PressurePublished by American Medical Association (AMA) ,1997
- Rational prescribing and sources of informationSocial Science & Medicine, 1982
- Differential education concerning therapeutics and resultant physician prescribing patternsAcademic Medicine, 1972